Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × chiauranib × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Gynecologic 2 Sarcoma 1 Other solid neoplasm 1 Lymphoid 1 Gastrointestinal 1

Conditions

Interventions

Radiotherapy 135 Cyclophosphamide 104 Temozolomide 103 Doxorubicin 102 Filgrastim 72 Ifosfamide 64 Imatinib Mesylate 63 Etoposide 62 Bevacizumab 52 Vincristine 49 Irinotecan 42 Gemcitabine 41 Peripheral Blood Stem Cell Transplantation 39 Methotrexate 36 Radiation 34 Cisplatin 31 Carboplatin 31 pazopanib 30 fludarabine phosphate 30 Busulfan 29 Trabectedin 28 Melphalan 26 Sirolimus 25 Docetaxel 23 Sunitinib 22 Magnetic Resonance Spectroscopy 22 Granulocyte Colony-Stimulating Factor 22 Cyclosporine 22 Carmustine 22 sargramostim 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05497843 2025-04-03

Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)

Chipscreen Biosciences, Ltd.

Phase 2 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡